207
Views
41
CrossRef citations to date
0
Altmetric
Review

Clinical characterization and molecular mechanisms of statin myopathy

, &
Pages 955-969 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Joseph V. Pergolizzi$suffix/text()$suffix/text(), Flaminia Coluzzi, Robert D. Colucci, Hanna Olsson, Jo Ann LeQuang, Jonathan Al-Saadi & Peter Magnusson. (2020) Statins and muscle pain. Expert Review of Clinical Pharmacology 13:3, pages 299-310.
Read now
Marie-Jeanne Bertrand & Jean-Claude Tardif. (2017) Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis. Expert Opinion on Emerging Drugs 22:1, pages 1-26.
Read now
Klara Kuncova, Marie Sedlackova, Jiri Vencovsky, Herman Mann, Michal Tomcik, Laszlo Wenchich & Josef Zamecnik. (2014) Inflammatory myopathy associated with statins: report of three cases. Modern Rheumatology 24:2, pages 366-371.
Read now
Marcello Arca & Giovanni Pigna. (2011) Treating statin-intolerant patients. Diabetes, Metabolic Syndrome and Obesity 4, pages 155-166.
Read now
Peter P Toth & Thomas D Dayspring. (2011) Drug safety evaluation of rosuvastatin. Expert Opinion on Drug Safety 10:6, pages 969-986.
Read now
Grant T. Generaux, Fiorenza M. Bonomo, Marta Johnson & Kelly M. Mahar Doan. (2011) Impact of SLCO1B1 (OATP1B1) and ABCG2 (BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins. Xenobiotica 41:8, pages 639-651.
Read now
Thura T Abd & Terry A Jacobson. (2011) Statin-induced myopathy: a review and update. Expert Opinion on Drug Safety 10:3, pages 373-387.
Read now
Adie Viljoen & Anthony S Wierzbicki. (2009) Towards companion diagnostics for the management of statin therapy. Expert Opinion on Medical Diagnostics 3:6, pages 659-671.
Read now
Peter P. Toth, Victoria Zarotsky, Jane M. Sullivan & Dave Laitinen. (2009) Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol. Current Medical Research and Opinion 25:6, pages 1355-1363.
Read now

Articles from other publishers (32)

Stephan Wenninger. (2022) Notfälle bei Patienten mit neuromuskulären Erkrankungen. Notfallmedizin up2date 17:02, pages 189-206.
Crossref
Pierandrea Vinci, Emiliano Panizon, Letizia Maria Tosoni, Carla Cerrato, Federica Pellicori, Filippo Mearelli, Chiara Biasinutto, Nicola Fiotti, Filippo Giorgio Di Girolamo & Gianni Biolo. (2021) Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy. International Journal of Molecular Sciences 22:21, pages 11687.
Crossref
Misha F. Vrolijk, Sonja Koppel & Florence Hunsel. (2020) Red yeast rice ( Monascus purpureus ) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb . British Journal of Clinical Pharmacology 87:4, pages 2146-2151.
Crossref
Oscar Vicente Vergara Serpa, Carlos Andrés Reyes Jaraba, Alonso Cortina Gutiérrez, Mario Enrique Montoya Jaramillo & Oscar Darío Echenique Torres. (2021) Rhabdomyolysis induced by long-term consumption of energy drinks associated with low intensity physical exercise: Case report. Revista Colombiana de Reumatología (English Edition) 28:2, pages 145-151.
Crossref
Oscar Vicente Vergara Serpa, Carlos Andrés Reyes Jaraba, Alonso Cortina Gutiérrez, Mario Enrique Montoya Jaramillo & Oscar Darío Echenique Torres. (2021) Rabdomiólisis inducida por consumo crónico de bebidas energizantes asociado a ejercicio físico de baja intensidad: reporte de caso. Revista Colombiana de Reumatología 28:2, pages 145-151.
Crossref
Hamid Mollazadeh, Erfan Tavana, Giovanni Fanni, Simona Bo, Maciej Banach, Matteo Pirro, Stephan von Haehling, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) Effects of statins on mitochondrial pathways. Journal of Cachexia, Sarcopenia and Muscle 12:2, pages 237-251.
Crossref
Amirhossein Sahebkar, Arrigo F.G. Cicero, Paolo Di Giosia, Irene Pomilio, Cosimo Andrea Stamerra, Paolo Giorgini, Claudio Ferri, Stephan Haehling, Maciej Banach & Tannaz Jamialahmadi. (2020) Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system. Journal of Cachexia, Sarcopenia and Muscle 11:5, pages 1177-1186.
Crossref
Ngee Kiat Chua, Hudson W. Coates & Andrew J. Brown. (2020) Squalene monooxygenase: a journey to the heart of cholesterol synthesis. Progress in Lipid Research 79, pages 101033.
Crossref
Dieter Heuß. (2020) S1-Leitlinie: Diagnostik und Differenzialdiagnose bei MyalgienS1 guideline: diagnostic workup and differential diagnosis of myalgia. DGNeurologie 3:3, pages 206-222.
Crossref
Raúl Ariza Andraca,  José  Halabe Cherem & Alberto  Lifshitz Guinzberg. (2020) Intolerancia y miopatía por estatinas. Acta Médica Grupo Ángeles 18:3, pages 290-295.
Crossref
Mohammad Altamimi, Souzan Zidan & Manal Badrasawi. (2020) Effect of Tree Nuts Consumption on Serum Lipid Profile in Hyperlipidemic Individuals: A Systematic Review. Nutrition and Metabolic Insights 13, pages 117863882092652.
Crossref
Peter P. Toth. 2020. Statin-Associated Muscle Symptoms. Statin-Associated Muscle Symptoms 5 19 .
Peter P. Toth. 2019. Comprehensive Cardiovascular Medicine in the Primary Care Setting. Comprehensive Cardiovascular Medicine in the Primary Care Setting 39 69 .
Beatriz Wills-Sanín, Alejandra Rincón, Ana Cristina Montenegro & Andrés F. Buitrago-Sandoval. (2017) Inhibidores de la paraproteína convertasa subtilisina/kexina tipo 9: una alternativa de manejo para las dislipidemias. Revista Colombiana de Cardiología 24:4, pages 411-416.
Crossref
Edvard Ehler & Josef Zámečník. (2016) Toxic myopathies. Neurologie pro praxi 17:6, pages 386-390.
Crossref
Maciej Banach, Tomas Stulc, Ricardo Dent & Peter P. Toth. (2016) Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement. International Journal of Cardiology 225, pages 184-196.
Crossref
Xu-lei Cui, Ying-lin Wang, Gang Tan, Ai-lun Luo & Xiang-yang Guo. (2016) Low-dose Simvastatin Increases Skeletal Muscle Sensitivity to Caffeine and Halothane. Chinese Medical Sciences Journal 31:2, pages 107-115.
Crossref
Yuichi J. Shimada & Christopher P. Cannon. (2015) PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future. European Heart Journal 36:36, pages 2415-2424.
Crossref
Eliano Pio NavareseMichalina KołodziejczakVolker SchulzePaul A. GurbelUdaya TantryYingfeng LinMaximilian BrockmeyerDavid E. KandzariJulia M. KubicaRalph B. D'AgostinoSr.Sr., Jacek KubicaMassimo VolpeStefan AgewallDean J. KereiakesMalte Kelm. (2015) Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia. Annals of Internal Medicine 163:1, pages 40-51.
Crossref
Paolo Magni, Chiara Macchi, Beatrice Morlotti, Cesare R. Sirtori & Massimiliano Ruscica. (2015) Risk identification and possible countermeasures for muscle adverse effects during statin therapy. European Journal of Internal Medicine 26:2, pages 82-88.
Crossref
Werner Kramer. 2016. Metabolic Control. Metabolic Control 373 435 .
Razvan T. Dadu & Christie M. Ballantyne. (2014) Lipid lowering with PCSK9 inhibitors. Nature Reviews Cardiology 11:10, pages 563-575.
Crossref
Adam D. Pirie, Noel W. Davies, Kiran D.K. Ahuja, Murray J. Adams, Cecilia M. Shing, Christian Narkowicz, Glenn A. Jacobson & Dominic P. Geraghty. (2014) Hypolipidaemic effect of crude extract from Carpobrotus rossii (pigface) in healthy rats. Food and Chemical Toxicology 66, pages 134-139.
Crossref
Jennifer A. Shannon, Samuel M. John, Harish S. Parihar, Shari N. Allen & Jenna J. Ferrara. (2013) A Clinical Review of Statin-Associated Myopathy. Journal of Pharmacy Technology 29:5, pages 219-230.
Crossref
Binh An P. Phan & Peter P. Toth. (2013) Is the Future of Statins Aligned with New Novel Lipid Modulation Therapies?. Current Atherosclerosis Reports 15:2.
Crossref
Klara Kuncova, Marie Sedlackova, Jiri Vencovsky, Herman Mann, Michal Tomcik, Laszlo Wenchich & Josef Zamecnik. (2012) Inflammatory myopathy associated with statins: report of three cases. Modern Rheumatology.
Crossref
Sivakumar Sathasivam. (2012) Statin induced myotoxicity. European Journal of Internal Medicine 23:4, pages 317-324.
Crossref
Peter P. Toth. 2011. Comprehensive Cardiovascular Medicine in the Primary Care Setting. Comprehensive Cardiovascular Medicine in the Primary Care Setting 59 89 .
Charles R. Harper & Terry A. Jacobson. (2010) Evidence-Based Management of Statin Myopathy. Current Atherosclerosis Reports 12:5, pages 322-330.
Crossref
Peter P. Toth. (2010) Drug Treatment of Hyperlipidaemia. Drugs 70:11, pages 1363-1379.
Crossref
Terry A. Jacobson. (2009) Myopathy with statin–fibrate combination therapy: clinical considerations. Nature Reviews Endocrinology 5:9, pages 507-518.
Crossref
Peter P. Toth, Victoria Zarotsky, Jane M. Sullivan & Dave Laitinen. (2008) Lipid therapy utilization rates in a managed-care mixed dyslipidemia population. Journal of Clinical Lipidology 2:5, pages 365-374.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.